CLINICAL SIGNIFICANCE OF ANTI-ADALIMUMAB ANTIBODIES IN RHEUMATOID ARTHRITIS, ANKYLOSING SPONDILITIS AND PSORIASIC ARTHRITIS

被引：2

作者：

Hoxha, A. ^{[1
]}

Calligaro, A. ^{[1
]}

Tonello, M. ^{[1
]}

Carletto, A. ^{[2
]}

Paolazzi, G. ^{[3
]}

Bortolotti, R. ^{[3
]}

Felicetti, M. ^{[1
]}

Ramonda, R. ^{[1
]}

Del Rossi, T. ^{[1
]}

Grava, C. ^{[4
]}

Boaretto, M. ^{[4
]}

Favaro, M. ^{[1
]}

Teghil, V. ^{[1
]}

Ruffatti, A. ^{[1
]}

Punzi, L. ^{[1
]}

机构：

[1] Univ Padua, Dept Med, Padua, Italy

[2] Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy

[3] Santa Chiara Hosp, Rheumatol Unit, Trento, Italy

[4] San Martino Hosp, Dept Med, Belluno, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷

关键词：

D O I：

10.1136/annrheumdis-2014-eular.5938

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0371

引用

页码：927 / 927

页数：1

共 50 条

[41] Thromboembolic Events Are Not Associated with Anti-Adalimumab Antibodies
Burmester, Gerd
Gabay, Cem
Arikan, Dilek
Cardoso, Anabela
Kalabic, Jasmina
Pfeifer, Nathan
Varothai, Nupun A.
Florentinus, Stefan
Smolen, Josef S.
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[42] The influence of anti-adalimumab antibodies on adalimumab through levels, TNF-α levels and clinical outcome
Bodini, G.
Giannini, E.
Pellegatta, G.
Demarzo, G.
Marabotto, E.
Furnari, M.
Baldissarro, I.
Savarino, V.
[J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 88 - 88
[43] Clinical measures in rheumatoid arthritis and ankylosing spondylitis
Fendler, C.
Braun, J.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S80 - S82
[44] Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
N. Inanc
E. Dalkılıc
S. Kamalı
E. Kasapoglu-Günal
Y. Elbir
H. Direskeneli
M. Inanc
[J]. Clinical Rheumatology, 2007, 26 : 17 - 23
[45] The influence of anti-adalimumab antibodies on adalimumab trough levels, TNF-α levels and clinical outcome
Bodini, G.
Savarino, V.
Dulbecco, P.
Baldissarro, I.
Savarino, E.
[J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S42 - S42
[46] Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
Inanc, N.
Dalkilic, E.
Kamali, S.
Kasapoglu-Gunal, E.
Elbir, Y.
Direskeneli, H.
Inanc, M.
[J]. CLINICAL RHEUMATOLOGY, 2007, 26 (01) : 17 - 23
[47] THE INFLUENCE OF ANTI-ADALIMUMAB ANTIBODIES ON ADALIMUMAB THROUGH LEVELS, TNF-α LEVELS AND CLINICAL OUTCOME
Bodini, G.
Savarino, V.
Dulbecco, P.
Baldissarro, I.
Savarino, E.
[J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E94 - E95
[48] Clinical Significance of Diabetes-Mellitus-Associated Antibodies in Rheumatoid Arthritis
Erlandsson, Malin C.
Tuameh, Mahomud
Huduti, Elin Jukic
Silfversward, Sofia T.
Pullerits, Rille
Bokarewa, Maria, I
[J]. CELLS, 2022, 11 (22)
[49] ANTIKERATIN ANTIBODIES IN RHEUMATOID-ARTHRITIS - METHODS AND CLINICAL-SIGNIFICANCE
KIRSTEIN, H
MATHIESEN, FK
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1987, 16 (05) : 331 - 337
[50] SIGNIFICANCE OF ANTIKERATIN ANTIBODIES IN RHEUMATOID-ARTHRITIS
HAJIROUSSOU, VJ
SKINGLE, J
GILLETT, AP
WEBLEY, M
[J]. JOURNAL OF RHEUMATOLOGY, 1985, 12 (01) : 57 - 59

← 1 2 3 4 5 →